Angion Biomedica Corp Probability of Future Stock Price Finishing Over 10.00
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
Angion |
Angion Biomedica Target Price Odds to finish over 10.00
The tendency of Angion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.00 | 90 days | 10.00 | near 1 |
Based on a normal probability distribution, the odds of Angion Biomedica to move above the current price in 90 days from now is near 1 (This Angion Biomedica Corp probability density function shows the probability of Angion Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Angion Biomedica has a beta of 0.71. This suggests as returns on the market go up, Angion Biomedica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Angion Biomedica Corp will be expected to be much smaller as well. Additionally Angion Biomedica Corp has an alpha of 0.8064, implying that it can generate a 0.81 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Angion Biomedica Price Density |
| Price |
Predictive Modules for Angion Biomedica
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Angion Biomedica Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Angion Biomedica Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Angion Biomedica is not an exception. The market had few large corrections towards the Angion Biomedica's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Angion Biomedica Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Angion Biomedica within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.81 | |
β | Beta against Dow Jones | 0.71 | |
σ | Overall volatility | 1.39 | |
Ir | Information ratio | 0.12 |
Angion Biomedica Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Angion Biomedica for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Angion Biomedica Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Angion Biomedica is not yet fully synchronised with the market data | |
| Angion Biomedica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.3 M. Net Loss for the year was (38.81 M) with loss before overhead, payroll, taxes, and interest of (15.8 M). | |
| Angion Biomedica Corp currently holds about 63.37 M in cash with (38.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1. | |
| Roughly 33.0% of the company shares are held by company insiders |
Angion Biomedica Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Angion Stock often depends not only on the future outlook of the current and potential Angion Biomedica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Angion Biomedica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30 M | |
| Cash And Short Term Investments | 50.5 M |
Angion Biomedica Technical Analysis
Angion Biomedica's future price can be derived by breaking down and analyzing its technical indicators over time. Angion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Angion Biomedica Corp. In general, you should focus on analyzing Angion Stock price patterns and their correlations with different microeconomic environments and drivers.
Angion Biomedica Predictive Forecast Models
Angion Biomedica's time-series forecasting models is one of many Angion Biomedica's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Angion Biomedica's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Angion Biomedica Corp
Checking the ongoing alerts about Angion Biomedica for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Angion Biomedica Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Angion Biomedica is not yet fully synchronised with the market data | |
| Angion Biomedica has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.3 M. Net Loss for the year was (38.81 M) with loss before overhead, payroll, taxes, and interest of (15.8 M). | |
| Angion Biomedica Corp currently holds about 63.37 M in cash with (38.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1. | |
| Roughly 33.0% of the company shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |